News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imugene.
RELATED STOCKHEAD STORIES
News
Weekly ASX Small Cap Wrap: Who’s passed the test this week?
Health & Biotech
Imugene gains 10pc on cancer vaccine progress; 3 other biotechs getting patents
Health & Biotech
Chimeric IPO: What ASX stockspert Bhavdip143 likes so much about the $35m CAR T play
Health & Biotech
Imugene, Immutep both complete recruitment for cancer treatment studies
Health & Biotech
First patient dosed with Imugene’s lung cancer drug candidate
Health & Biotech
Check Up: Rhythm leads ASX health stocks on progress on replacement for poo tests
News
ASX Small Cap Lunch Wrap: Who’s on target for their best month in 32 years?
News
Last Orders: What you might have missed on the ASX today
News
10 at 10: These ASX stocks have conquered the greatest depths this morning
Health & Biotech
Pharmaxis to get $14m payday after its cystic fibrosis treatment Bronchitol approved by FDA
Stockhead TV
ASX small caps leading the fight against cancer
Guides
ASX stocks capital raising guide: Here’s everything you need to know
Health & Biotech
Dr Boreham’s Crucible: Kazia reaches the ‘endgame’
Health & Biotech
Advance Nanotek boss reiterates threat to quit the ASX
Experts
Scopo’s powerplays: It just won’t go down!
News
10 at 10: These ASX stocks are starry-eyed this morning
News
